Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-011-1647-3.

Title:
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes | Breast Cancer Research and Treatment
Description:
The prognostic significance of tumor-associated FOXP3+ regulatory T cells (Tregs) and CD8+ cytotoxic T lymphocytes (CTLs) in invasive breast carcinomas is studied. Tregs and CTLs were assessed by immunohistochemistry in 1270 cases of invasive breast carcinoma for their associations with patient survival, histopathologic features, and molecular subtypes. Infiltrates of Tregs and CTLs were observed within tumor bed and in the tissue surrounding tumor. Within tumor bed, increased infiltration of Tregs and CTLs was significantly more common in those with unfavorable histologic features, including high histologic grade and negative ER and PR status. In addition, high density Treg infiltration was also associated with tumor HER2 overexpression, decreased overall survival (OS) and progression-free survival (PFS). In tissue surrounding tumor, in contrast, high CTL/Treg ratio was found to be significantly associated with improved OS and PFS. These prognostic associations were confirmed by multivariate analysis. Furthermore, the density of Treg infiltrates within tumors was inversely correlated with the prognosis of the molecular subtypes of tumors. The ratio of CTL/Treg infiltrates in the surrounding tissue was also significantly higher in luminal than non-luminal subtypes of carcinoma. The prognostic significances of Tregs and CTLs in breast carcinoma depend on their relative density and location. The density of intratumoral Treg infiltrates and the peritumoral CTL/Treg ratio are independent prognostic factors and correlated with the prognosis of the molecular subtypes of breast carcinoma, which may serve as potential target for stratifying immunotherapy to battle against the aggressive subtypes of breast carcinoma.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, cancer, pubmed, google, scholar, breast, cas, cells, regulatory, carcinoma, tumor, cell, survival, subtypes, lymphocytes, clin, prognostic, research, cytotoxic, molecular, res, access, tumorinfiltrating, foxp, infiltration, tregs, infiltrates, privacy, cookies, content, ctls, invasive, density, prognosis, intratumoral, outcome, med, oncol, publish, search, lang, zhang, fan, surrounding, high, ratio, tumors, immunotherapy, open, human,

Topics {✒️}

tumor-infiltrating t-cells—friend month download article/chapter small-cell lung cancer vanderbilt–ingram cancer center peritumoral ctl/treg ratio high ctl/treg ratio full article pdf related subjects innovative research team privacy choices/manage cookies tumor-infiltrating cytotoxic infiltrating ductal carcinoma tumor-infiltrating lymphocytes tumor infiltrating lymphocytes adverse clinical outcome temple university hospital invasive breast carcinoma invasive breast carcinomas cells predict outcome ctl/treg infiltrates tissue surrounding tumor invasive micropapillary carcinoma cheang mc metastatic breast cancer breast cancer prevention breast carcinoma depend inhibits tumor growth intratumoral lymphoid structures pancreatic ductal adenocarcinorna epithelial ovarian cancer breast cancer subtypes breast cancer survival tumor-infiltrating foxp3+ li fu tumor her2 overexpression tumor specific cytolysis vanderbilt epidemiology center tumor-infiltrating cd4 t-regulatory cells cell infiltrates varies european economic area unfavorable histologic features progression-free survival conejo-garcia jr long-term follow article liu breast cancer pathology independent prognostic factors pathological prognostic factors conditions privacy policy

Questions {❓}

  • Parmiani G (2005) Tumor-infiltrating T-cells—friend or foe of neoplastic cells?
  • Yu P, Fu YX (2006) Tumor-infiltrating T lymphocytes: friends or foes?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
         description:The prognostic significance of tumor-associated FOXP3+ regulatory T cells (Tregs) and CD8+ cytotoxic T lymphocytes (CTLs) in invasive breast carcinomas is studied. Tregs and CTLs were assessed by immunohistochemistry in 1270 cases of invasive breast carcinoma for their associations with patient survival, histopathologic features, and molecular subtypes. Infiltrates of Tregs and CTLs were observed within tumor bed and in the tissue surrounding tumor. Within tumor bed, increased infiltration of Tregs and CTLs was significantly more common in those with unfavorable histologic features, including high histologic grade and negative ER and PR status. In addition, high density Treg infiltration was also associated with tumor HER2 overexpression, decreased overall survival (OS) and progression-free survival (PFS). In tissue surrounding tumor, in contrast, high CTL/Treg ratio was found to be significantly associated with improved OS and PFS. These prognostic associations were confirmed by multivariate analysis. Furthermore, the density of Treg infiltrates within tumors was inversely correlated with the prognosis of the molecular subtypes of tumors. The ratio of CTL/Treg infiltrates in the surrounding tissue was also significantly higher in luminal than non-luminal subtypes of carcinoma. The prognostic significances of Tregs and CTLs in breast carcinoma depend on their relative density and location. The density of intratumoral Treg infiltrates and the peritumoral CTL/Treg ratio are independent prognostic factors and correlated with the prognosis of the molecular subtypes of breast carcinoma, which may serve as potential target for stratifying immunotherapy to battle against the aggressive subtypes of breast carcinoma.
         datePublished:2011-06-30T00:00:00Z
         dateModified:2011-06-30T00:00:00Z
         pageStart:645
         pageEnd:655
         sameAs:https://doi.org/10.1007/s10549-011-1647-3
         keywords:
            Breast carcinoma
            Cytotoxic T cell
            Regulatory T cell
            Survival
            Molecular subtype
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig4_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:130
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Fangfang Liu
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ronggang Lang
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jing Zhao
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinmin Zhang
               affiliation:
                     name:Temple University Hospital
                     address:
                        name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gordon A. Pringle
               affiliation:
                     name:Temple University Hospital
                     address:
                        name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu Fan
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dong Yin
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feng Gu
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhi Yao
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Li Fu
               affiliation:
                     name:Tianjin Medical University Cancer Institute & Hospital
                     address:
                        name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
      description:The prognostic significance of tumor-associated FOXP3+ regulatory T cells (Tregs) and CD8+ cytotoxic T lymphocytes (CTLs) in invasive breast carcinomas is studied. Tregs and CTLs were assessed by immunohistochemistry in 1270 cases of invasive breast carcinoma for their associations with patient survival, histopathologic features, and molecular subtypes. Infiltrates of Tregs and CTLs were observed within tumor bed and in the tissue surrounding tumor. Within tumor bed, increased infiltration of Tregs and CTLs was significantly more common in those with unfavorable histologic features, including high histologic grade and negative ER and PR status. In addition, high density Treg infiltration was also associated with tumor HER2 overexpression, decreased overall survival (OS) and progression-free survival (PFS). In tissue surrounding tumor, in contrast, high CTL/Treg ratio was found to be significantly associated with improved OS and PFS. These prognostic associations were confirmed by multivariate analysis. Furthermore, the density of Treg infiltrates within tumors was inversely correlated with the prognosis of the molecular subtypes of tumors. The ratio of CTL/Treg infiltrates in the surrounding tissue was also significantly higher in luminal than non-luminal subtypes of carcinoma. The prognostic significances of Tregs and CTLs in breast carcinoma depend on their relative density and location. The density of intratumoral Treg infiltrates and the peritumoral CTL/Treg ratio are independent prognostic factors and correlated with the prognosis of the molecular subtypes of breast carcinoma, which may serve as potential target for stratifying immunotherapy to battle against the aggressive subtypes of breast carcinoma.
      datePublished:2011-06-30T00:00:00Z
      dateModified:2011-06-30T00:00:00Z
      pageStart:645
      pageEnd:655
      sameAs:https://doi.org/10.1007/s10549-011-1647-3
      keywords:
         Breast carcinoma
         Cytotoxic T cell
         Regulatory T cell
         Survival
         Molecular subtype
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1647-3/MediaObjects/10549_2011_1647_Fig4_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:130
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Fangfang Liu
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ronggang Lang
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jing Zhao
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinmin Zhang
            affiliation:
                  name:Temple University Hospital
                  address:
                     name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gordon A. Pringle
            affiliation:
                  name:Temple University Hospital
                  address:
                     name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu Fan
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dong Yin
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feng Gu
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhi Yao
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Li Fu
            affiliation:
                  name:Tianjin Medical University Cancer Institute & Hospital
                  address:
                     name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:130
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
      name:Temple University Hospital
      address:
         name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
         type:PostalAddress
      name:Temple University Hospital
      address:
         name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
         type:PostalAddress
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
      name:Tianjin Medical University Cancer Institute & Hospital
      address:
         name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Fangfang Liu
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Ronggang Lang
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Jing Zhao
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Xinmin Zhang
      affiliation:
            name:Temple University Hospital
            address:
               name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Gordon A. Pringle
      affiliation:
            name:Temple University Hospital
            address:
               name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Yu Fan
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Dong Yin
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Feng Gu
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Zhi Yao
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      name:Li Fu
      affiliation:
            name:Tianjin Medical University Cancer Institute & Hospital
            address:
               name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
      name:Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, USA
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      name:Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(138)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.34s.